Medical Subject Headings
MeSH Tree Structures - 2014
C15 - Hemic and Lymphatic Diseases
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Anemia [C15.378.071]
- Anemia, Aplastic [C15.378.071.085]
- Anemia, Hemolytic [C15.378.071.141]
- Anemia, Hemolytic, Autoimmune [C15.378.071.141.125]
- Anemia, Hemolytic, Congenital [C15.378.071.141.150]
- Anemia, Dyserythropoietic, Congenital [C15.378.071.141.150.095]
- Anemia, Hemolytic, Congenital Nonspherocytic [C15.378.071.141.150.100]
- Anemia, Sickle Cell [C15.378.071.141.150.150]
- Elliptocytosis, Hereditary [C15.378.071.141.150.365]
- Glucosephosphate Dehydrogenase Deficiency [C15.378.071.141.150.480]
- Hemoglobin C Disease [C15.378.071.141.150.490]
- Spherocytosis, Hereditary [C15.378.071.141.150.785]
- Thalassemia [C15.378.071.141.150.875]
- Favism [C15.378.071.141.370]
- Hemoglobinuria, Paroxysmal [C15.378.071.141.560]
- Hemolytic-Uremic Syndrome [C15.378.071.141.610]
- Anemia, Hypochromic [C15.378.071.196]
- Anemia, Macrocytic [C15.378.071.252]
- Anemia, Myelophthisic [C15.378.071.307]
- Anemia, Neonatal [C15.378.071.363]
- Anemia, Refractory [C15.378.071.400]
- Anemia, Sideroblastic [C15.378.071.419]
- Red-Cell Aplasia, Pure [C15.378.071.750]
- Blood Coagulation Disorders [C15.378.100]
- Blood Coagulation Disorders, Inherited [C15.378.100.100]
- Activated Protein C Resistance [C15.378.100.100.037]
- Afibrinogenemia [C15.378.100.100.056]
- Antithrombin III Deficiency [C15.378.100.100.075]
- Bernard-Soulier Syndrome [C15.378.100.100.080]
- Factor V Deficiency [C15.378.100.100.300]
- Factor VII Deficiency [C15.378.100.100.310]
- Factor X Deficiency [C15.378.100.100.320]
- Factor XI Deficiency [C15.378.100.100.325]
- Factor XII Deficiency [C15.378.100.100.330]
- Factor XIII Deficiency [C15.378.100.100.335]
- Hemophilia A [C15.378.100.100.500]
- Hemophilia B [C15.378.100.100.510]
- Hermanski-Pudlak Syndrome [C15.378.100.100.515]
- Hypoprothrombinemias [C15.378.100.100.550]
- Protein C Deficiency [C15.378.100.100.690]
- Thrombasthenia [C15.378.100.100.820]
- von Willebrand Diseases [C15.378.100.100.900]
- Wiskott-Aldrich Syndrome [C15.378.100.100.970]
- Coagulation Protein Disorders [C15.378.100.141]
- Activated Protein C Resistance [C15.378.100.141.036]
- Afibrinogenemia [C15.378.100.141.072]
- Factor V Deficiency [C15.378.100.141.300]
- Factor VII Deficiency [C15.378.100.141.310]
- Factor X Deficiency [C15.378.100.141.320]
- Factor XI Deficiency [C15.378.100.141.325]
- Factor XII Deficiency [C15.378.100.141.330]
- Factor XIII Deficiency [C15.378.100.141.335]
- Hemophilia A [C15.378.100.141.500]
- Hemophilia B [C15.378.100.141.510]
- Hypoprothrombinemias [C15.378.100.141.550]
- von Willebrand Diseases [C15.378.100.141.900]
- Disseminated Intravascular Coagulation [C15.378.100.220]
- Ecchymosis [C15.378.100.452]
- Platelet Storage Pool Deficiency [C15.378.100.685]
- Protein S Deficiency [C15.378.100.800]
- Purpura [C15.378.100.802]
- Thrombocythemia, Essential [C15.378.100.832]
- Vitamin K Deficiency [C15.378.100.920]
- Blood Coagulation Disorders, Inherited [C15.378.100.100]
- Blood Group Incompatibility [C15.378.120]
- Blood Platelet Disorders [C15.378.140]
- Bernard-Soulier Syndrome [C15.378.140.120]
- Gray Platelet Syndrome [C15.378.140.427]
- Platelet Storage Pool Deficiency [C15.378.140.735]
- Thrombasthenia [C15.378.140.810]
- Thrombocytopenia [C15.378.140.855]
- Thrombocytosis [C15.378.140.860]
- von Willebrand Diseases [C15.378.140.900]
- Blood Protein Disorders [C15.378.147]
- Agammaglobulinemia [C15.378.147.142]
- Antithrombin III Deficiency [C15.378.147.150]
- Dysgammaglobulinemia [C15.378.147.333]
- Hypergammaglobulinemia [C15.378.147.542]
- Hypoproteinemia [C15.378.147.607]
- Paraproteinemias [C15.378.147.780]
- Protein C Deficiency [C15.378.147.880]
- Protein S Deficiency [C15.378.147.890]
- Bone Marrow Diseases [C15.378.190]
- Anemia, Aplastic [C15.378.190.196]
- Bone Marrow Neoplasms [C15.378.190.250]
- Myelodysplastic-Myeloproliferative Diseases [C15.378.190.615]
- Myelodysplastic Syndromes [C15.378.190.625]
- Myeloproliferative Disorders [C15.378.190.636]
- Anemia, Myelophthisic [C15.378.190.636.085]
- Leukemia, Erythroblastic, Acute [C15.378.190.636.276]
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive [C15.378.190.636.370]
- Leukemia, Neutrophilic, Chronic [C15.378.190.636.380]
- Leukemoid Reaction [C15.378.190.636.484]
- Polycythemia Vera [C15.378.190.636.753]
- Primary Myelofibrosis [C15.378.190.636.765]
- Thrombocytosis [C15.378.190.636.860]
- Hematologic Neoplasms [C15.378.400]
- Hemoglobinopathies [C15.378.420]
- Hemorrhagic Disorders [C15.378.463]
- Afibrinogenemia [C15.378.463.067]
- Bernard-Soulier Syndrome [C15.378.463.080]
- Disseminated Intravascular Coagulation [C15.378.463.250]
- Factor V Deficiency [C15.378.463.300]
- Factor VII Deficiency [C15.378.463.310]
- Factor X Deficiency [C15.378.463.320]
- Factor XI Deficiency [C15.378.463.325]
- Factor XII Deficiency [C15.378.463.330]
- Factor XIII Deficiency [C15.378.463.335]
- Hemophilia A [C15.378.463.500]
- Hemophilia B [C15.378.463.510]
- Hemostatic Disorders [C15.378.463.515]
- Cryoglobulinemia [C15.378.463.515.140]
- Ehlers-Danlos Syndrome [C15.378.463.515.240]
- Hemangioma, Cavernous [C15.378.463.515.385]
- Multiple Myeloma [C15.378.463.515.460]
- Pseudoxanthoma Elasticum [C15.378.463.515.530]
- Purpura, Hyperglobulinemic [C15.378.463.515.550]
- Purpura, Schoenlein-Henoch [C15.378.463.515.580]
- Scurvy [C15.378.463.515.800]
- Shwartzman Phenomenon [C15.378.463.515.810]
- Telangiectasia, Hereditary Hemorrhagic [C15.378.463.515.900]
- Waldenstrom Macroglobulinemia [C15.378.463.515.960]
- Hypoprothrombinemias [C15.378.463.550]
- Platelet Storage Pool Deficiency [C15.378.463.735]
- Purpura, Thrombocytopenic, Idiopathic [C15.378.463.740]
- Thrombasthenia [C15.378.463.810]
- Thrombocythemia, Essential [C15.378.463.825]
- Vitamin K Deficiency [C15.378.463.841]
- von Willebrand Diseases [C15.378.463.920]
- Waterhouse-Friderichsen Syndrome [C15.378.463.950]
- Wiskott-Aldrich Syndrome [C15.378.463.960]
- Leukocyte Disorders [C15.378.553]
- Eosinophilia [C15.378.553.231]
- Infectious Mononucleosis [C15.378.553.381]
- Leukocytosis [C15.378.553.475]
- Leukopenia [C15.378.553.546]
- Leukostasis [C15.378.553.560]
- Pelger-Huet Anomaly [C15.378.553.696]
- Phagocyte Bactericidal Dysfunction [C15.378.553.774]
- Methemoglobinemia [C15.378.619]
- Pancytopenia [C15.378.700]
- Polycythemia [C15.378.738]
- Pregnancy Complications, Hematologic [C15.378.785]
- Preleukemia [C15.378.800]
- Sulfhemoglobinemia [C15.378.896]
- Thrombophilia [C15.378.925]
- Anemia [C15.378.071]
- Lymphatic Diseases [C15.604]
- Histiocytosis [C15.604.250]
- Histiocytic Disorders, Malignant [C15.604.250.390]
- Histiocytosis, Langerhans-Cell [C15.604.250.400]
- Histiocytosis, Non-Langerhans-Cell [C15.604.250.410]
- Lymphadenitis [C15.604.315]
- Lymphangiectasis [C15.604.360]
- Lymphangitis [C15.604.406]
- Lymphatic Abnormalities [C15.604.451]
- Lymphedema [C15.604.496]
- Lymphocele [C15.604.510]
- Lymphoproliferative Disorders [C15.604.515]
- Agammaglobulinemia [C15.604.515.032]
- Autoimmune Lymphoproliferative Syndrome [C15.604.515.138]
- Giant Lymph Node Hyperplasia [C15.604.515.245]
- Granuloma [C15.604.515.292]
- Heavy Chain Disease [C15.604.515.435]
- Immunoblastic Lymphadenopathy [C15.604.515.509]
- Infectious Mononucleosis [C15.604.515.516]
- Leukemia, Hairy Cell [C15.604.515.553]
- Leukemia, Lymphoid [C15.604.515.560]
- Lymphangiomyoma [C15.604.515.562]
- Lymphoma [C15.604.515.569]
- Composite Lymphoma [C15.604.515.569.150]
- Hodgkin Disease [C15.604.515.569.355]
- Intraocular Lymphoma [C15.604.515.569.417]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Burkitt Lymphoma [C15.604.515.569.480.100]
- Lymphoma, B-Cell [C15.604.515.569.480.150]
- Burkitt Lymphoma [C15.604.515.569.480.150.165]
- Lymphoma, AIDS-Related [C15.604.515.569.480.150.450]
- Lymphoma, B-Cell, Marginal Zone [C15.604.515.569.480.150.570]
- Lymphoma, Large B-Cell, Diffuse [C15.604.515.569.480.150.585]
- Lymphoma, Primary Effusion [C15.604.515.569.480.150.592]
- Lymphomatoid Granulomatosis [C15.604.515.569.480.150.600]
- Lymphoma, Follicular [C15.604.515.569.480.350]
- Lymphoma, Large-Cell, Anaplastic [C15.604.515.569.480.487]
- Lymphoma, Large-Cell, Immunoblastic [C15.604.515.569.480.493]
- Lymphoma, Mantle-Cell [C15.604.515.569.480.525]
- Lymphoma, T-Cell [C15.604.515.569.480.750]
- Enteropathy-Associated T-Cell Lymphoma [C15.604.515.569.480.750.399]
- Lymphoma, T-Cell, Cutaneous [C15.604.515.569.480.750.800]
- Lymphoma, T-Cell, Peripheral [C15.604.515.569.480.750.825]
- Marek Disease [C15.604.515.700]
- Sarcoidosis [C15.604.515.827]
- Sezary Syndrome [C15.604.515.841]
- Tumor Lysis Syndrome [C15.604.515.880]
- Waldenstrom Macroglobulinemia [C15.604.515.925]
- Mucocutaneous Lymph Node Syndrome [C15.604.560]
- Pseudolymphoma [C15.604.613]
- Splenic Diseases [C15.604.744]
- Thymus Hyperplasia [C15.604.816]
- Thymus Neoplasms [C15.604.861]
- Tuberculosis, Lymph Node [C15.604.921]
- Histiocytosis [C15.604.250]
- Hematologic Diseases [C15.378]
Copyright, Privacy, Accessibility, Site Map, Viewers and Players
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act, NLM Customer Support
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act, NLM Customer Support
